Characteristics of the increase in plasma brain natriuretic peptide level in left ventricular systolic dysfunction, associated with muscular dystrophy in comparison with idiopathic dilated cardiomyopathy

Neuromuscular Disorders

Volumn 14, Issue 11, 2004, Pages 732-739

  Demachi, Jun ^a   Kagaya, Yutaka ^a   Watanabe, Jun ^a   Sakuma, Masahito ^a   Ikeda, Jun ^a   Kakuta, Yasunori ^b   Motoyoshi, Iyoko ^b   Kohnosu, Takeshi ^b   Sakuma, Hiroaki ^b   Shimazaki, Shigeru ^b   Sakai, Hideaki ^b   Kimpara, Teiko ^b   Takahashi, Toshiaki ^b   Omura, Kiyoshi ^b   Okada, Miho ^b   Saito, Hiroshi ^b   Shirato, Kunio ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Sendai Nishitaga Hospital   (Japan)

Author keywords

Brain natriuretic peptide; Dilated cardiomyopathy; Left ventricular ejection fraction; Muscular dystrophy

Indexed keywords

NATRIURETIC FACTOR; PEPTIDE DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; BRAIN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; MUSCULAR DYSTROPHY; PARAMETER; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADULT; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MUSCULAR ATROPHY; NATRIURETIC PEPTIDE, BRAIN; STATISTICS, NONPARAMETRIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 5144224072     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2004.08.002     Document Type: Article

References (35)

1. R. Worton Muscular dystrophies: diseases of the dystrophin-glycoprotein complex Science 270 1995 755 756
2. G. Nigro, L.I. Comi, and F.M. Limongelli Prospective study of X-linked progressive muscular dystrophy in Campania Muscle Nerve 6 1983 253 262
3. J.M. de Kermadec, H.M. Becane, A. Chenard, F. Tertrain, and Y. Weiss Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study Am Heart J 127 1994 618 623
4. K. Sasaki, K. Sakata, E. Kachi, S. Hirata, T. Ishihara, and K. Ishikawa Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study Am Heart J 135 1998 937 944
5. K. Brockmeier, L. Schmitz, A. von Moers, H. Koch, M. Vogel, and G. Bein X-chromosomal (p21) muscular dystrophy and left ventricular diastolic and systolic function Pediatr Cardiol 19 1998 139 144
6. P. Melacini, M. Fanin, and G.A. Danieli Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy Circulation 94 1996 3168 3175
7. M. Mukoyama, K. Kondo, K. Hizawa, and H. Nishitani Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan J Neurol Sci 81 1987 155 158
8. G. Corrado, A. Lissoni, and S. Beretta Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy Am J Cardiol 89 2002 838 841
9. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
10. T. Tsutamoto, A. Wada, and K. Maeda Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
11. F. Liang, and D.G. Gardner Mechanical strain activates BNP gene transcription through a p38/NF-kappaB-dependent mechanism J Clin Invest 104 1999 1603 1612
12. K. Mori, T. Manabe, M. Nii, Y. Hayabuchi, Y. Kuroda, and K. Tatara Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy Pediatr Cardiol 23 2002 160 166
13. C.A. Swinyard, G.G. Deaver, and L. Greenspan Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases Arch Phys Med Rehab 38 1957 574 579
14. Y. Koseki, J. Watanabe, and T. Shinozaki Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan Circ J 67 2003 431 436
15. L.E. Teichholtz, M.V. Cohen, and E.H. Sonnenblick Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy N Engl J Med 291 1974 1220 1226
16. N. Nagaya, T. Nishikimi, and Y. Goto Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction Am Heart J 135 1998 21 28
17. S. Yasuda, Y. Goto, and T. Baba Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function J Am Coll Cardiol 36 2000 115 121
18. B.A. Groenning, J.C. Nilsson, L. Sondergaard, A. Kjaer, H.B. Larsson, and P.R. Hildebrandt Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations Eur J Heart Fail 3 2001 699 708
19. S. Voutilainen, M. Kupari, M. Hippelainen, K. Karppinen, M. Ventila, and J. Heikkila Factors influencing Doppler indexes of left ventricular filling in healthy persons Am J Cardiol 68 1991 653 659
20. S. Voutilainen, M. Kupari, M. Hippelainen, K. Karppinen, and M. Ventila Age-dependent influence of heart rate on Doppler indexes of left ventricular filling J Intern Med 235 1994 435 441
21. J.S. Gottdiener, H.A. Gross, W.L. Henry, J.S. Borer, and M.H. Ebert Effects of self-induced starvation on cardiac size and function in anorexia nervosa Circulation 58 1978 425 433
22. G. de Simone, L. Scalfi, and M. Galderisi Cardiac abnormalities in young women with anorexia nervosa Br Heart J 71 1994 287 292
23. C. Romano, M. Chinali, and F. Pasanisi Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosa Am J Clin Nutr 77 2003 308 312
24. K.A. Frankel, and R.J. Rosser The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis Hum Pathol 7 1976 375 386
25. K. Mori, T. Manabe, M. Nii, Y. Hayabuchi, Y. Kuroda, and K. Tatara Myocardial integrated backscatter in patients with Duchennne's progressibe muscular dystrophy Heart 86 2001 341 342
26. J. Wynne, and E. Braunwald Dilated cardiomyopathy E. Braunwald D.P. Zipes P. Libby Heart disease 6th ed. 2001 W.B. Saunders Philadelphia, PA 1754 1759
27. A. Matsumoto, Y. Hirata, and S. Momomura Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction Am Heart J 129 1995 139 145
28. M. Yousufuddin, M.Y. Henein, and M. Flather Incremental importance of peak-exercise plasma levels of endothelin-1 and natriuretic peptides in chronic heart failure J Cardiovasc Pharmacol 38 2001 468 473
29. R.A. Nishimura, and A.J. Tajik Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone J Am Coll Cardiol 30 1997 8 18
30. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr, D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic J Am Med Assoc 289 2003 194 202
31. R.W. Troughton, D.L. Prior, and J.J. Pereira Plasma B-type natriuretic peptide levels in systolic heart failure. Importance of left ventricular diastolic function and right ventricular systolic function J Am Coll Cardiol 43 2004 416 422
32. C.A. Kelly, D.E. Newby, and T.A. McDonagh Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema: effects on plasma brain natriuretic peptide concentrations Eur Heart J 23 2002 1379 1386
33. Y. Ishikawa, J.R. Bach, and R. Minami Cardioprotection for Duchenne's muscular dystrophy Am Heart J 137 1999 895 902
34. R.E. Shaddy, L.Y. Tani, and S.S. Gidding Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience J Heart Lung Transplant 18 1999 269 274
35. V. Giglio, V. Pasceri, and L. Messano Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy J Am Coll Cardiol 42 2003 309 316